NEXT/Virginia Cancer Specialists

Fairfax, Virginia 22031

1 studies enrolling now · 5 studies all time

What they study most

Adenoid Cystic Carcinoma, Advanced Solid Tumor, Advanced Solid Tumors, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, HER2 Amplification, HER2 Gene Mutation, HER2 Mutant Non-small Cell Lung Cancer, HER2-positive Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma

Studies at this site

• A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors. — Recruiting now
• A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors — Running, not enrolling
• A Study of HFB301001 in Adult Patients With Advanced Solid Tumors — Stopped early
• ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer — Running, not enrolling
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC — Running, not enrolling